Výsledky vyhledávání - "Erica C. Nakajima"

Akademický článek

Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.

Autor: Erica C Nakajima, Michael P Frankland, Tucker F Johnson, Sanja L Antic, Heidi Chen, Sheau-Chiann Chen, Ronald A Karwoski, Ronald Walker, Bennett A Landman, Ryan D Clay, Brian J Bartholmai, Srinivasan Rajagopalan, Tobias Peikert, Pierre P Massion, Fabien Maldonado

Publikováno v: PLoS ONE, Vol 13, Iss 6, p e0198118 (2018)

Lung adenocarcinoma (ADC), the most common lung cancer type, is recognized increasingly as a disease spectrum. To guide individualized patient care, a non-invasive means of distinguishing indolent from aggressive ADC subtypes is needed urgently. Comp

Externí odkaz: https://doaj.org/article/526159792d044ac1a95ad2c359f6c425

Zobrazit plný text záznamu

Plný text ve formátu HTML

FDA Approval Summary: Sotorasib for KRAS G12C Mutated Metastatic NSCLC

Autor: Erica C. Nakajima, Nicole Drezner, Xiaoxue Li, Pallavi S. Mishra-Kalyani, Yajun Liu, Hong Zhao, Youwei Bi, Jiang Liu, Atiqur Rahman, Emily Wearne, Idara Ojofeitimi, Lauren Tesh Hotaki, Dianne Spillman, Richard Pazdur, Julia A. Beaver, Harpreet Singh

Publikováno v: Clin Cancer Res

On May 28, 2021, the FDA granted accelerated approval to sotorasib (Lumakras, Amgen) for the treatment of adults with advanced non–small cell lung cancer (NSCLC) with a Kirsten rat sarcoma proto-oncogene (KRAS) G12C mutation who have received at le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747866cb2c952dfd16c25124d4e235bc
https://europepmc.org/articles/PMC9012672/

Zobrazit plný text záznamu

Innovation in recruitment and curricular design for diversity, equity, and inclusion (DEI) education for hematology-oncology (HO) trainees

Autor: S. M. Qasim Hussaini, Samuel Rosner, Erica C. Nakajima, Marcus Messmer, Tanyanika Phillips, Rakhi Prakash Naik, Ross C. Donehower, Kristen Marrone

Publikováno v: Journal of Clinical Oncology. 40:179-179

179 Background: Alongside persistent disparities in healthcare outcomes in HO, there is an inability to adequately recruit, maintain and promote a diverse and inclusive work force nationwide. To our knowledge, a structured approach to DEI education/r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f13286a57bfb86ce2f722b9405ee9c49
https://doi.org/10.1200/jco.2022.40.28_suppl.179

Zobrazit plný text záznamu

Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event

Autor: Evan J. Lipson, Julie R. Brahmer, Erica C. Nakajima

Publikováno v: Journal of Clinical Oncology. 37:2714-2718

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c0b2bc0da48cbd3e659f314053c875
https://doi.org/10.1200/jco.19.01623

Zobrazit plný text záznamu

Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis

Autor: Erica C. Nakajima, Yi Ren, Jonathon Joseph Vallejo, Oladimeji Akinboro, Pallavi Shruti Mishra-Kalyani, Erin A. Larkins, Nicole Lauren Drezner, Shenghui Tang, Richard Pazdur, Julia A. Beaver, Harpreet Singh

Publikováno v: Journal of Clinical Oncology. 40:9001-9001

9001 Background: While existing data suggest a detriment of immune checkpoint inhibitors (ICI) in other targetable mutations in non-small cell lung cancer (NSCLC), limited retrospective analyses suggest patients with Kirsten rat sarcoma oncogene ( KR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::510cb1267b7a70271571df0d2a1c7246
https://doi.org/10.1200/jco.2022.40.16_suppl.9001

Zobrazit plný text záznamu

Akademický článek

Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions.

Autor: Erica C Nakajima, Charles Laymon, Matthew Oborski, Weizhou Hou, Lin Wang, Jennifer R Grandis, Robert L Ferris, James M Mountz, Bennett Van Houten

Publikováno v: PLoS ONE, Vol 9, Iss 8, p e102452 (2014)

PURPOSE:Intratumoral metabolic heterogeneity may increase the likelihood of treatment failure due to the presence of a subset of resistant tumor cells. Using a head and neck squamous cell carcinoma (HNSCC) xenograft model and a real-time fluorescence

Externí odkaz: https://doaj.org/article/4b81cfef71f341b4936a1a565acd080f

Zobrazit plný text záznamu

FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma

Autor: Somak Chatterjee, Martha Donoghue, Pallavi S. Mishra-Kalyani, Harpreet Singh, Erin Larkins, Hong Zhao, Missiratch Biable, Youwei Bi, Julia A. Beaver, Jiang Liu, Hisham Qosa, Richard Pazdur, Erica C Nakajima, Paz J. Vellanki, Lauren Tesh Hotaki, Yuan Li Shen

Publikováno v: Clin Cancer Res

On October 2, 2020, FDA approved nivolumab with ipilimumab as first-line treatment for adult patients with unresectable malignant pleural mesothelioma (MPM). The approval was based on results from Study CA209743 (CHECKMATE-743), an open-label trial o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447f93a506322a4ba9d4950c4848a080
https://pubmed.ncbi.nlm.nih.gov/34462287

Zobrazit plný text záznamu

Hematology/medical oncology fellow responses to the initial development of an antiracism curriculum

Autor: Victor Moyo, Marcus Messmer, Erica C. Nakajima, Luckson Noe Mathieu, Catherine Handy Marshall, Honor Sanderford, Ross C. Donehower, Kristen A. Marrone, Colin D. Weekes, Jennifer Marie Jones, Tanyanika Phillips

Publikováno v: Journal of Clinical Oncology. 39:11042-11042

11042 Background: While the American Council on Graduate Medical Education (ACGME) set up a Planning Committee for Diversity in GME in 2018, no formalized milestones or training mandates have been announced. The nation-wide protests for racial justic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5356375d79d162d3028f313393ec751e
https://doi.org/10.1200/jco.2021.39.15_suppl.11042

Zobrazit plný text záznamu

CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC)

Autor: Jamie E. Chaft, Hao Wang, Jeffrey P. Leal, Martin G. Pomper, Patrick M. Forde, Matthew D. Hellmann, Erica C. Nakajima, Wei Fu

Publikováno v: Journal of Clinical Oncology. 38:9031-9031

9031 Background: An early biomarker of response to immunotherapy (IO) is needed urgently to identify the patients (pts) who will derive benefit. We reported the first clinical trial of neoadjuvant IO (nIO) in resectable non-small cell lung cancer (NS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::99cf533263e6d1a5a373debaec0949b0
https://doi.org/10.1200/jco.2020.38.15_suppl.9031

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání